SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced ...

SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company" or "23andMe"), announced today the completion of the previously announced 1-for-20 reverse stock sp ...

SUNNYVALE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced ...

23andMe, named because of the number of chromosome pairs in human DNA, raised more than $1.1bn before its hotly awaited IPO ...

SUNNYVALE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company" or "23andMe"), announced today that the 1-for-20 reverse stock split of the Company's Class A and ...

The 1-20 reverse split was announced on Friday ... Institutional investors own 36.10% of the company’s stock. 23andMe Holding Co operates as a consumer genetics testing company.

Here is a look at why companies split their stocks and why stock splits matter. Plus, upcoming splits to watch from 23andMe ...

23Andme is a genetics-based consumer healthcare and therapeutics company. On October 11, the company announced a 1-for-20 reverse stock split of its Class A and Class B common stock. Shares will ...

These are the upcoming stock splits for the week of October 14 to October 18, based on TipRanks’ Stock Splits Calendar. A ...

23andMe, a genetic-testing and ancestry-tracing ... in a de-identified manner for research purposes, however, you can reverse that consent, but cannot retract data that's already been shared.

Amid financial challenges, DNA testing company 23andMe is reportedly exploring a potential sale, which could place the genetic data of over 15 million customers in the hands of new ownership.